Page Menu

Cells and Microbes

Immunology, virology, and bacterial pathogenesis are active interdisciplinary biomedical fields with studies ranging from molecular mechanisms to clinical trials. The Immunology & Virology Program (IVP) is administered by the Immunology and Virology Committee, an interdepartmental group that includes faculty with diverse research interests, including the molecular and cellular basis of immune responsiveness, molecular mechanisms of viral replication, host-pathogen interactions, and the control of viral, bacterial and parasitic infections.

Perturbing Nucleic Acid Sensing in Murine Models - Ann Rothstein, Kate Fitzgerald Labs and Kevin M. Gao

Perturbing Nucleic Acid Sensing in Murine Models - Ann Rothstein, Kate Fitzgerald Labs and Kevin M. Gao

Perturbing Nucleic Acid Sensing in Murine Models
to Identify Novel Mechanisms of Auto-immunity and Auto-inflammation

Ann Rothstein, Kate Fitzgerald Labs and Kevin M. Gao

 

Kevin-Rothstein-Fitzgerald-pic1.png Kevin-Rothstein-Fitzgerald-pic2.png
Ann-Rothstein.png

Dr. Rothstein has a long-standing interest in factors regulating the activation of autoreactive T and B cells. Her lab was the first group to demonstrate that members of the Toll-like receptor (TLR) family can detect mammalian nucleic acid ligands and that TLR9 or TLR7 play a key role in the activation of autoreactive B cells. Her current interests focus on the distinct roles of TLR7 and TLR9 in the pathogenesis of systemic autoimmune diseases, utilizing an inducible rapid onset model of cutaneous lupus. In related studies, she is exploring the role of cytosolic (eg. STING) and endosomal (TLR) sensors in models of autoinflammation resulting from constitutive activation of STING due to DNAseII deficiency or STING gain-of-function mutations. Additional projects revolve around the pro-apoptotic and pro-inflammatory functions of membrane-bound FasL and how these activities can be regulated by metalloproteinase-mediated cleavage of the extracellular FasL domain. Rothstein Lab

Kevin-Gao.png

Kevin joined the lab in November of 2018. His thesis research is centered on the regulation of immune cells by nucleic acid (NA) pattern recognition receptors (PRRs) in the pathogenesis of auto-immune and auto-inflammatory diseases. Because microbial and host-derived NA are both abundant, organisms restrain the immune system from acting non-discriminately and have developed strategies to discern inert signals from dangerous signals. Our labs utilize two murine models which perturb these control mechanisms: STING Associated Vasculopathy with onset in Infancy (SAVI), wherein a gain-of-function mutation in STING results in constitutive activation of the cytosolic dsDNA sensing pathway cGAS-STING, and DNaseII deficiency, wherein loss of an endosomal Dnase leads to impaired NA debris clearance. Using these models, Kevin hopes to identify mechanisms by which activation of NA sensors differentially regulates adaptive and innate immune cells, and how these mechanisms converge to coordinate multi-organ inflammation.
Kevin.Gao@umassmed.edu

Kate-Fitzgerald.png

Dr. Fitzgerald’s has a long-standing interest in macrophages and innate immunity with a focus both on host-defense and sterile inflammation. Her group leverages cellular and molecular approaches to understand the mechanisms regulating inflammatory cytokine production. Her lab utilizes these multifaceted approaches to understand how the host responds to microbial infection and how the inflammatory process is regulated in order to avoid dangerous inflammatory responses and autoimmune disease. Her lab is particularly well-recognized for work on type I interferon gene regulation, TLR signaling pathways, inflammasome biology, long-non-coding RNAs and cytosolic DNA sensors. Ongoing projects include exploration of the molecular mechanisms that account for the autoinflammatory phenotype of mice and patients with STING gain-of-function mutations. The ultimate aim is to identify new paradigms in diagnosing and treating human disease through a deeper understanding of the molecular mechanisms regulating inflammation.
Fitzgerald Lab

Investigating the Role of VPS13D in Autophagy - Eric Baehrecke Lab and James L. Shen

Investigating the Role of VPS13D in Autophagy - Eric Baehrecke Lab and James L. Shen

Investigating the Role of VPS13D in Autophagy

Eric Baehrecke Lab and James L. Shen


Investigating the Role of VPS13D in Autophagy

Eric-Baehrecke.png
We are studying the mechanisms that control autophagy, a process that is required to maintain the health of cells. Defects in autophagy lead to cell stress and have been associated with many disorders, including common and rare diseases. We use Drosophila, mammalian cell lines and mice as models to study autophagy, and our work focuses on understanding how autophagy functions in different cells and tissues, as well as under different types of cell stress.
Baehrecke Lab
James-Shen.png
Defects in autophagy, the self-degradation of cellular components, are linked to multiple disorders such as cancer, diabetes and neurodegenerative diseases. I investigate the role of vps13d, an essential gene with relatively unknown function, in context-specific autophagy in the developing Drosophila intestine. My preliminary finding suggest that this gene plays a crucial role in regulating mitophagy and mitochondrial morphology. I employ advanced Drosophila genetics, confocal microscropy and proteomics to investigate this hypothesis.
James.Shen@umassmed.edu
Mechanisms of inflammatory cell death pathways in primary human cells - Kate Fitzgerald Lab and Jeffrey Zhou

Mechanisms of inflammatory cell death pathways in primary human cells - Kate Fitzgerald Lab and Jeffrey Zhou

Mechanisms of inflammatory cell death pathways in primary human cells

Kate Fitzgerald Lab and Jeffrey Zhou

Jeffrey-Zhou-research.png

Kate-Fitzgerald.png

Dr. Fitzgerald is interested in the molecular mechanisms of innate immune signaling. Her lab utilizes biochemical, molecular, and genetic tools to perform research on a diversity of topics, including type I interferons, cytosolic sensors of DNA, inflammasome biology, and immune-related long-non-coding RNAs. The lab’s long-term goals are to understand how dysregulation of innate immunity contributes to the pathogenesis of infectious, autoinflammatory, and autoimmune diseases.
Fitzgerald Lab

Jeffrey-Zhou.png

Jeff joined the Fitzgerald lab in September 2018. His research is focused on innate immune pathways in human primary cells. In particular, he studies inflammasomes⁠—multimeric cytosolic sensors of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) which can elicit inflammatory cell death known as pyroptosis. He is particularly interested in the NLRP1/CARD8 proteins that are poorly conserved between murine and human systems, as well as inflammasome pathways activated by dsDNA. By pursuing human models of inflammation, Jeff hopes to bridge knowledge gaps in mouse-human immunology to improve understanding of human autoinflammatory diseases.
Jeffrey.Zhou@umassmed.edu